^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Oncuria™

    Company:
    Nonagen BioSci
    Type:
    CE Marked
    Details
    Evidence
    News
    over3years
    Urine-based #bladdercancer diagnosis-BlaDimiR (miRNAs) promising-University Hospital 12 de Octubre, Madrid-cytology is conventional-ImmunoCyt, UroVysion, BTA stat, NMP22 seldom used? Emerging-utDNA, Oncuria? #DrHidekiFuruya @CSCancerCare https://t.co/SEm8tAOSZ2 @practiceupdate ()
    Clinical
    |
    Oncuria™ • UroVysion™ Bladder Cancer Kit (UroVysion Kit)
    over3years
    #NonagenBioscience announces CE mark for #Oncuria #BladderCancer diagnostic https://t.co/9COwboUvLj ()
    Oncuria™